| Patents for A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy (86,964) |
|---|
| 01/19/2000 | EP0971731A1 Suppression of malignancy utilizing ribonucleotide reductase r1 |
| 01/19/2000 | EP0971724A1 Expression of active human factor ix in mammary tissue of transgenic animals |
| 01/19/2000 | EP0971712A1 Compositions for the inhibition of bone resorption |
| 01/19/2000 | EP0971693A2 Method of making microencapsulated dna for vaccination and gene therapy |
| 01/19/2000 | EP0971692A2 Specific magnetosome, method for the production and use thereof |
| 01/19/2000 | EP0848616A4 Glucocorticoid enhancement of gene expression |
| 01/19/2000 | EP0841950A4 Neuronal progenitor cells and uses thereof |
| 01/19/2000 | CN1242045A Immunotherapy and improved vaccines |
| 01/19/2000 | CN1241636A Nuclease plasmid resisting HPV16E6 and its application in treatment of human papilloma virus and tumor |
| 01/19/2000 | CN1048403C Production technology for traditional herb medicines photosensitizer |
| 01/18/2000 | US6015938 Osteoprotegerin |
| 01/18/2000 | US6015897 For conjugation to ligand/antiligand pair and use in delivery of therapeutic or diagnostic agent to targeted site |
| 01/18/2000 | US6015894 Oligonucleotide modulation of cell adhesion |
| 01/18/2000 | US6015893 Oligonucleoside compounds and methods for inhibiting tumor growth, invasion and metastasis |
| 01/18/2000 | US6015892 Nucleotide sequences for diagnosis and treatment of related disorders; antisense/anticarcinogenic/antitumor agents; antiinflammatory/antiproliferative agents |
| 01/18/2000 | US6015883 Amino acid sequence of purified chemokine polypeptide; treatment of immune deficiency diseases, autoimmune diseases, allergies or asthma; anticarcinogenic/antiinflammatory/ antiarthritic agents |
| 01/18/2000 | US6015876 Treating medical and laboratory equipment and supplies, suspensions, solutions, blood, blood products, and tissues by contacting with viricidal protein, peptide, or conjugate |
| 01/18/2000 | US6015713 Transgenic fish and a method of harvesting islet cells therefrom |
| 01/18/2000 | US6015712 Antisense modulation of FADD expression |
| 01/18/2000 | US6015694 Method for stimulating an immune response utilizing recombinant alphavirus particles |
| 01/18/2000 | US6015688 Transferrin receptor genes |
| 01/18/2000 | US6015686 A eukaryotic promoter 5' of viral cdna which initiates within a cell the 5' to 3' synthesis of rna from complementary dna producing a vector construct which autonomously amplifies in a cell and expresses an heterologous sequence; gene therapy |
| 01/18/2000 | US6015676 Simple, specific and nontoxic method by transporting carboxylated single-stranded antisense probes in a delivery vector into cells, hybridizing to messenger rna with natural amino-groups causing covalent base pairing |
| 01/18/2000 | US6015669 Identification of genes |
| 01/18/2000 | US6015665 Method and composition for regulating apoptosis |
| 01/18/2000 | US6015660 Borna disease viral sequences, diagnostics and therapeutics for nervous system diseases |
| 01/18/2000 | US6015556 Cytotoxic drug therapy |
| 01/18/2000 | US6015554 Method of reconstituting human lymphoid and dendritic cells |
| 01/13/2000 | WO2000001851A1 Antisense oligonucleotides targeted to il-15 |
| 01/13/2000 | WO2000001837A1 (-)-strand rna virus vector for nerve cell |
| 01/13/2000 | WO2000001835A2 Targeted integration into chromosomes using retroviral vectors |
| 01/13/2000 | WO2000001834A1 Recombinant herpes viruses for preparing recombinant adeno-associated viruses |
| 01/13/2000 | WO2000001818A1 Human emr1-like g protein coupled receptor |
| 01/13/2000 | WO2000001816A1 TUMOUR SUPPRESSOR GENE DBCCR1 AT 9q32-33 |
| 01/13/2000 | WO2000001815A2 Neurotrophic factors |
| 01/13/2000 | WO2000001813A2 Peptide inhibitors of androgen-independent activation of androgen receptor |
| 01/13/2000 | WO2000001811A1 Kv6.2, A VOLTAGE-GATED POTASSIUM CHANNEL SUBUNIT |
| 01/13/2000 | WO2000001728A1 Galectin 11 |
| 01/13/2000 | WO2000001720A2 Compositions and methods for treating papillomavirus-infected cells |
| 01/13/2000 | WO2000001440A2 Methods for treating neurological injuries and disorders |
| 01/13/2000 | WO2000001418A1 Transgene expression in polarized cells |
| 01/13/2000 | WO2000001393A2 OLIGONUCLEOTIDE INHIBITORS OF bcl-xL |
| 01/13/2000 | WO1999060148A3 Display of viral proteins as ligands for cell-surface receptor |
| 01/13/2000 | WO1999060135A8 Generation of multiple gene products from chimeric fusion proteins by cleavage with ubiquitous endoproteases |
| 01/13/2000 | WO1999053047A3 Porcine adenovirus type 3 genome |
| 01/13/2000 | WO1999037774A3 Differentiation-associated sequences and methods of use therefor |
| 01/13/2000 | DE19830874A1 Verfahren zur Stabilisierung und Verbesserung des Gentransfers von genetischem Material in Säugerzellen A process for the stabilization and improvement of the gene transfer of genetic material into mammalian cells |
| 01/13/2000 | DE19830141A1 Rekombinante Herpesviren für die Erzeugung rekombinanter Adeno-Assoziierter-Viren Recombinant herpes viruses for the production of recombinant adeno-associated virus |
| 01/13/2000 | CA2337794A1 Transgene expression in polarized cells |
| 01/13/2000 | CA2336718A1 Methods for treating neurological injuries and disorders |
| 01/13/2000 | CA2336406A1 Galectin 11 |
| 01/13/2000 | CA2336384A1 Oligonucleotide inhibitors of bcl-xl |
| 01/13/2000 | CA2332699A1 Antisense oligonucleotides targeted to il-15 |
| 01/13/2000 | CA2331829A1 Kv6.2, a voltage-gated potassium channel subunit |
| 01/13/2000 | CA2331394A1 Human emr1-like g protein coupled receptor |
| 01/13/2000 | CA2302169A1 Inhibitors of androgen-independent activation of androgen receptor |
| 01/12/2000 | EP0970243A1 Diagnosis and treatment of glaucoma |
| 01/12/2000 | EP0970232A2 Non-immunogenic prodrugs and selectable markers for use in gene therapy |
| 01/12/2000 | EP0970227A1 Recombinant antibodies and immunoconjugates targeted to cd-22 bearing cells and tumors |
| 01/12/2000 | EP0970226A1 Vectors having enhanced expression, and methods of making and uses thereof |
| 01/12/2000 | EP0970210A1 Methods of modulating p33ing1 mediated apoptosis |
| 01/12/2000 | EP0970207A1 Heregulin variants |
| 01/12/2000 | EP0970205A2 Human endosulfine gene |
| 01/12/2000 | EP0970203A2 Agents for pre-symptomatic detection and therapeutic targeting of alzheimer's disease and down syndrome in humans |
| 01/12/2000 | EP0970186A1 SpoOJ2 OF STAPHYLOCOCCUS AUREUS |
| 01/12/2000 | EP0970106A1 uPAR MIMICKING PEPTIDE |
| 01/12/2000 | EP0969885A1 Process for stimulating neural regeneration |
| 01/12/2000 | EP0969877A1 Methods for the modulation of the growth of collateral arteries and/or other arteries from preexisting arteriolar connections |
| 01/12/2000 | EP0969876A2 Delivery system for gene therapy to the brain |
| 01/12/2000 | EP0969875A1 Adenoviral-vector-mediated gene transfer into medullary motor neurons |
| 01/12/2000 | EP0969865A1 Mhc class ii antigen-presenting systems and methods for activating cd4?+ t cells |
| 01/12/2000 | EP0969864A1 Hiv p-17 peptide fragment, compositions containing and methods for producing and using same |
| 01/12/2000 | EP0969862A2 SYNTHETIC HIV $i(GAG) GENES |
| 01/12/2000 | EP0969861A1 Inhibiting hiv infection by cleaving co-receptor rna |
| 01/12/2000 | EP0969858A1 RIBOSOME RECYCLING FACTOR (FRR) OF $i(STAPHYLOCOCCUS AUREUS) |
| 01/12/2000 | EP0969828A1 Butyrate prodrugs derived from lactic acid |
| 01/12/2000 | EP0969775A1 Bone marrow as a site for transplantation |
| 01/12/2000 | EP0969720A2 Combined tumor suppressor gene therapy and chemotherapy in the treatment of neoplasms |
| 01/12/2000 | EP0572401B1 Viral particles having altered host range |
| 01/12/2000 | EP0548234B1 Cloning of chicken anaemia dna |
| 01/12/2000 | CN1241216A Non-mammalian DNA virus having altered coat protein |
| 01/12/2000 | CN1241212A Compound and methods for immunotherapy and diagnosis of tuberculosis |
| 01/12/2000 | CN1241193A Meningococcus vaccine comprising valence of BZ23 strain |
| 01/11/2000 | US6013786 Nucleotide sequences used as inhibitors of the oncogenic action of the encoded protein; antitumor agents |
| 01/11/2000 | US6013780 VEGF145 expression vectors |
| 01/11/2000 | US6013765 Cell surface peptides that can be used as antitumor agents |
| 01/11/2000 | US6013638 Adenovirus comprising deletions on the E1A, E1B and E3 regions for transfer of genes to the lung |
| 01/11/2000 | US6013630 Using mutant atrial natriuretic factor proteins, fragments, analogs, derivatives and homologs thereof, the nucleic acids encoding these mutant proteins, and modulators of atrial natriuretic factor for treating or preventing ischemic stroke |
| 01/11/2000 | US6013526 Modified protein for gene transfer and process for producing the same |
| 01/11/2000 | US6013521 Culture system used for the maintenance of neuronal tissues; for use in the treatment of neuronal disorders and detection of neuronal modulators |
| 01/11/2000 | US6013516 Vector and method of use for nucleic acid delivery to non-dividing cells |
| 01/11/2000 | US6013505 Polynucleotide sequence coding a polypeptide in vovolved in coiling deoxyribonucleic acids; for diagnosis and antibiotic development against bacterial infection |
| 01/11/2000 | US6013497 Polynucleotide sequence that codes a polypeptide; bactericides |
| 01/11/2000 | US6013487 Chimeric RNA molecules generated by trans-splicing |
| 01/11/2000 | US6013482 Polynucleotide sequence coding a ahdesion protein that is on the surface of a cell; for screening drugs that modulate cell surface protein activity; diagnosis of bacterial infection; bactericides |
| 01/11/2000 | US6013479 Human Emr1-like G protein coupled receptor |
| 01/11/2000 | US6013477 Polypeptide molecule with cellular growth activity; for detecting mutations in the coding sequence of the polypeptide; wound healing agents; antiproliferative agents |
| 01/11/2000 | US6013476 DNA encoding tumor necrosis related receptor TR7 |
| 01/11/2000 | US6013473 Nucleic acid sequence encoding a deoxyribonucleic acid repair enzyme; for treatment, prevention, and diagnosing cancer; antitumor/anticarcinogenic agents |
| 01/11/2000 | US6013454 Kinesin-like motor protein |